Replimune Group, Inc. (REPL)

NASDAQ: REPL · Real-Time Price · USD

15.88

+0.08 (0.51%)

At close: Aug 26, 2026, 4:00 PM EDT

15.81

-0.07 (-0.43%)

After-hours: Aug 26, 2026, 7:30 PM EDT

Replimune Group Employees

Replimune Group had 465 employees as of March 31, 2026. The number of employees decreased by 14 or -2.92% compared to the previous year.

Employees

465

Change (1Y)

-14

Growth (1Y)

-2.92%

Revenue / Employee

n/a

Profits / Employee

-$638,738

Market Cap

1.50B

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2026	465	-14	-2.92%
Mar 31, 2025	479	148	44.71%
Mar 31, 2024	331	47	16.55%
Mar 31, 2023	284	78	37.86%
Mar 31, 2022	206	54	35.53%
Mar 31, 2021	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
MeiraGTx Holdings	393
Innoviva	159
ORIC Pharmaceuticals	111
Cullinan Therapeutics	109
Vor Biopharma	76
Savara	70
Alto Neuroscience	68
Apnimed	65

Employee Rankings

REPL News

17 hours ago - Replimune price target raised to $21 from $20 at JPMorgan - TheFly
1 day ago - REPL Stockholders Have Rights – If You Lost Money Investing in Replimune Group, Inc. Contact Robbins LLP for Information About Recovering Your Losses - GlobeNewsWire
7 days ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
10 days ago - Replimune files automatic mixed securities shelf - TheFly
12 days ago - Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update - GlobeNewsWire
12 days ago - Replimune Group Earnings release: Q1 2027 - Filings
12 days ago - Replimune Group Quarterly report: Q1 2027 - Filings
13 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL - PRNewsWire